WINNING THE BATTLE AGAINST ENDOTOXIC SEPTIC SHOCK
The first theranostic: EAA™ & Toraymyxin
Spectral welcomes the Mayo Clinic as its 19th site for the Tigris clinical trial
PRESS RELEASE
Spectral Medical Provides November Tigris Trial Update
79 patients enrolled TORONTO, Canada – December 4, 2023 - Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, today provided an update for the month...
Spectral Medical Announces CFO Departure
TORONTO, Canada – December 1, 2023 - Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, today announced that Blair McInnis has provided notice of...
Spectral Medical Announces Publication of Tigris Trial Methods Paper and Simulation of Results
Tomlinson et al. Bayesian methods: a potential path forward for sepsis trials. Critical Care (2023) 27:432 TORONTO, Canada – November 14, 2023 - Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing...
INVESTOR UPDATEs
Investor Update September 2023
EVENTS
Spectral to present at the virtual Sidoti Micro Cap Conference Thursday November 16th @ 9:15am ET
the balancing act on lifetime tv
Endotoxic Septic Shock as featured on The Balancing Act on Lifetime TV.
Monday September 11 | 7:30am (ET/PT)
apac 2023
Dr. Kellum presenting on numerous topics at The 5th Asia Pacific Acute Kidney Injury & Continuous Renal Replacement Therapy Congress (APAC) including Septic Shock and the Tigris Trial
September 21 – 24, 2023, Daegu, Korea